Genes and genetics of murine lupus

Systemic Lupus Erythematosus, Fourth Edition

Volumn , Issue , 2004, Pages 225-263

  Kono, Dwight H ^a   Baccala, Roberto ^b   Theofilopoulos, Argyrios N ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 1242282390     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012433901-9/50011-9     Document Type: Chapter

References (384)

1. A.N. Theofilopoulos and F.J. Dixon (1985) Murine models of systemic lupus erythematosus. Adv. Immunol. 37 269.
2. A.N. Theofilopoulos and D.H. Kono (1999) Murine lupus models: Gene-specific and genome-wide studies. R.G. Lahita (Ed.) Systemic Lupus Erythematosus San Diego: Academic Press 145.
3. J.G. Schoenecker, R.K. Johnson, A.P. Lesher, J.D. Day, S.D. Love, M.R. Hoffman, T.L. Ortel, W. Parker and J.H. Lawson (2001) Exposure of mice to topical bovine thrombin induces systemic autoimmunity. Am. J. Pathol. 159 1957.
4. P.A. Silveira and A.G. Baxter (2001) The NOD mouse as a model of SLE. Autoimmunity 34 53.
5. M.A. Jordan, P.A. Silveira, D.P. Shepherd, C. Chu, S.J. Kinder, J. Chen, L.J. Palmisano, L.D. Poulton and A.G. Baxter (2000) Linkage analysis of systemic lupus erythematosus induced in diabetes-prone nonobese diabetic mice by Mycobacterium bovis. J. Immunol. 165 1673.
6. B. Chiang, E. Bearer, A. Ansari, K. Dorshkind and M.E. Gershwin (1990) The MB12 mutation and autoantibodies to dsDNA in NZB.H-2bm12 mice. J. Immunol. 145 94.
7. R. Merino, L. Fossati, M. Lacour, R. Lemoine, M. Higaki and S. Izui (1992) H-2-linked control of the Yaa gene-induced acceleration of lupus-like autoimmune disease in BXSB mice. Eur. J. Immunol. 22 295.
8. M. Iwamoto, N. Ibnou-Zeki, K. Araki and S. Izui (1996) Prevention of murine lupus by an I-E alpha chain transgene: Protective role of I-E alpha chain-derived peptides with a high affinity to I-Ab molecules. Eur. J. Immunol. 26 307.
9. S. Hirose, R. Nagasawa, I. Sekikawa, M. Hamaoka, Y. Ishida, H. Sata and T. Shirai (1983) Enhancing effect of H-2 linked NZW genes on the autoimmune traits of (NZB × NZW)F1 mice. J. Exp. Med. 158 228.
10. B.L. Kotzin and E. Palmer (1987) The contribution of NZW genes to lupus-like disease in (NZB × NZW)F1 mice. J. Exp. Med. 165 1237.
11. H. Kawano, M. Abe, D. Zhang, T. Saikawa, M. Fujimori, S. Hirose and T. Shirai (1992) Heterozygosity of the major histocompatibility complex controls the autoimmune disease in (NZW × BXSB)F1 mice. Clin. Immunol. Immunopathol. 65 308.
12. L. Morel, U.H. Rudofsky, J.A. Longmate, J. Schiffenbauer and E.K. Wakeland (1994) Polygenic control of susceptibility to murine systemic lupus erythematosus. Immunity 1 219.
13. C.G. Drake, S.J. Rozzo, H.F. Hirschfeld, N.P. Smarnworawong, E. Palmer and B.L. Kotzin (1995) Analysis of the New Zealand Black contribution to lupus-like renal disease: Multiple genes that operate in a threshold manner. J. Immunol. 154 2441.
14. T.J. Vyse, S.J. Rozzo, C.G. Drake, V.B. Appel, M. Lemeur, S. Izui, E. Palmer and B.L. Kotzin (1998) Contributions of Ea(z) and Eb(z) MHC genes to lupus susceptibility in New Zealand mice. J. Immunol. 160 2757.
15. S.J. Rozzo, T.J. Vyse, C.S. David, E. Palmer, S. Izui and B.L. Kotzin (1999) Analysis of MHC class II genes in the susceptibility to lupus in New Zealand mice. J. Immunol. 162 2623.
16. N. Ibnou-Zekri, T.J. Vyse, S.J. Rozzo, M. Iwamoto, T. Kobayakawa, B.L. Kotzin and S. Izui (1999) MHC-linked control of murine SLE. Curr. Top. Microbiol. Immunol. 246 275.
17. R. Merino, M. Iwamoto, L. Fossati, P. Muniesa, K. Araki, S. Takahashi, J. Huarte, K. Yamamura, J.D. Vassalli and S. Izui (1993) Prevention of systemic lupus erythematosus in autoimmune BXSB mice by a transgene encoding 1-E alpha chain. J. Exp. Med. 178 1189.
18. N. Ibnou-Zekri, M. Iwamoto, L. Fossati, P. McConahey and S. Izui (1997) Role of the major histocompatibility complex class II Ea gene in lupus susceptibility in mice. Proc. Natl. Acad. Sci. USA 94 14654.
19. T. Fujimura, S. Hirose, Y. Jiang, S. Kodera, H. Ohmuro, D. Zhang, Y. Hamano, H. Ishida, S. Furukawa and T. Shirai (1998) Dissection of the effects of tumor necrosis factor-alpha and class II gene polymorphisms within the MHC on murine systemic lupus erythematosus (SLE). Int. Immunol. 10 1467.
20. C.O. Jacob, S.K. Lee and G. Strassmann (1996) Mutational analysis of TNF-alpha gene reveals a regulatory role for the 3′-untranslated region in the genetic predisposition to lupus-like autoimmune disease. J. Immunol. 156 3043.
21. M.C. Carroll (2000) The role of complement in B cell activation and tolerance. Adv. Immunol. 74 61.
22. Y. Zhang, S.F. Schlossman, R.A. Edwards, C.N. Ou, J. Gu and M.X. Wu (2002) Impaired apoptosis extended duration of immune responses and a lupus-like autoimmune disease in IEX-1-transgenic mice. Proc. Natl. Acad. Sci. USA 99 878.
23. L. Morel, X.H. Tian, B.P. Croker and E.K. Wakeland (1999) Epistatic modifiers of autoimmunity in a murine model of lupus nephritis. Immunity 11 131.
24. R. Watanabe-Fukunaga, C.I. Brannan, N. Itoh, S. Yonehara, N.G. Copeland, N.A. Jenkins and S. Nagata (1992) The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen. J. Immunol. 148 1274.
25. J. Drappa, N. Brot and K.B. Elkon (1993) The Fas protein is expressed at high levels on CD4+CD8+ thymocytes and activated mature lymphocytes in normal mice but not in the lupus-prone strain, MRL lpr/lpr. Proc. Natl. Acad. Sci. USA 90 10340.
26. M.R. Alderson, R.J. Armitage, E. Maraskovsky, T.W. Tough, E. Roux, Schooley, F. Ramsdell and D.H. Lynch (1993) Fas transduces activation signals in normal human T lymphocytes. J. Exp. Med. 178 2231.
27. D.H. Lynch, F. Ramsdell and M.R. Alderson (1995) Fas and FasL in the homeostatic regulation of immune responses. Immunol. Today 16 569.
28. T. Suda, T. Okazaki, Y. Naito, T. Yokota, N. Arai, S. Ozaki, K. Nakao and S. Nagata (1995) Expression of the Fas ligand in cells of T cell lineage. J. Immunol. 154 3806.
29. D. Bellgrau, D. Gold, H. Selawry, J. Moore, A. Franzusoff and R.C. Duke (1995) A role for CD95 ligand in preventing graft rejection. Nature 377 630.
30. T.S. Griffin, T. Brunner, S.M. Fletcher, D.R. Green and T.A. Ferguson (1995) Das ligand-induced apoptosis as a mechanism of immune privilege. Science 270 1189.
31. J.S. Hunt, D. Vassmer, T.A. Ferguson and L. Miller (1997) Fas ligand is positioned in mouse uterus and placenta to prevent trafficking of activated leukoytes between the mother and the conceptus. J. Immunol. 158 4122.
32. Y. Gao, J.M. Herndon, H. Zhang, T.S. Griffith and T.A. Ferguson (1998) Anti-inflammatory effects of CD95 ligand (FasL)-induced apoptosis. J. Exp. Med. 188 887.
33. H.J. Kaplan, M.A. Leibole, T. Tezel and T.A. Ferguson (1999) Fas ligand (CD95 ligand) controls angiogenesis beneath the retina. Natural Med. 5 292.
34. A. Oehm, I. Behrmann, W. Falk, M. Pawlita, G. Maier, C. Klas, M. Li-Weber, S. Richards, J. Dhein, B.C. Trauth, H. Ponstingl and P.H. Krammer (1992) Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily: Sequence identity with the Fas antigen. J. Biol. Chem. 267 10709.
35. R. Watanabe-Fukunaga, C.J. Brannan, N.G. Copeland, N.A. Jenkins and S. Nagata (1992) Lymphoproliferative disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356 314.
36. M. Adachi, R. Watanabe-Fukunaga and S. Nagata (1993) Aberrant transcription caused by the insertion of an early transposable element in an intron of the Fas antigen gene of lpr mice. Proc. Natl. Acad. Sci. USA 90 1756.
37. J.L. Chu, J. Drappa, A. Parnassa and K.B. Elkon (1993) The defect in Fas mRNA expression in MRL/lpr mice is associated with insertion of the retrotransposon, ETn. J. Exp. Med. 178 723.
38. J. Wu, T. Zhou, J. He and J.D. Mountz (1993) Autoimmune disease in mice due to integration of an endogenous retrovirus in an apoptosis gene. J. Exp. Med. 178 461.
39. S.M. Mariani, B. Matiba, E.A. Armandola and P.H. Krammer (1994) The APO-1/Fas (CD95) receptor is expressed in homozygous MRL/lpr mice. Eur. J. Immunol. 24 3119.
40. J.K. Booker, E.A. Reap and P.L. Cohen (1998) Expression and function of Fas on cells damaged by gamma-irradiation in B6 and B6/lpr mice. J. Immunol. 161 4536.
41. M. Adachi, S. Suematsu, T. Kondo, J. Ogasawara, T. Tanaka, N. Yoshida and S. Nagata (1995) Targeted mutation in the Fas gene causes hyperplasia of peripheral lymphoid organs and liver. Nature Genet. 11 294.
42. J.B. Roths, E.D. Murphy and E.M. Eicher (1984) A new mutation, gld, that produces lymphoproliferation and autoimmunity in C3H/HeJ mice. J. Exp. Med. 159 1.
43. D.H. Lynch, M.L. Watson, M.R. Alderson, P.R. Baum, R.E. Miller, T. Tough, M. Gibson, T. Davis-Smith, C.A. Smith, K. Hunter, D. Bhat, W. Din, R.G. Goodwin and M.F. Seldin (1994) The mouse Fas-ligand gene is mutated in gld mice and is part of a TNF family gene cluster. Immunity 1 131.
44. T. Takahashi, M. Tanaka, C.I. Brannan, N.A. Jenkins, N.G. Copeland, T. Suda and S. Nagata (1994) Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76 969.
45. M. Hahne, M.C. Peitsch, M. Irmier, M. Schroter, B. Lowin, M. Rousseau, C. Bron, T. Renno, L. French and J. Tschopp (1995) Characterization of the nonfunctional Fas ligand of gld mice. Int. Immunol. 7 1381.
46. E.D. Murphy and J.B. Roths (1976) A single gene for massive lymphoproliferation with immune complex disease in a new mouse strain MRL 69 1976.
47. Y. Ogata, M. Kimura, K. Shimada, T. Wakabayashi, H. Onoda, T. Katagiri and A. Matsuzawa (1993) Distinctive expression of lprcg in the heterozygous state on different genetic backgrounds. Cell. Immunol. 148 91.
48. F. Rieux-Laucat, F. Le Deist, C. Hivroz, I.A. Roberts, K.M. Debatin, A. Fischer and J.P. de Villartay (1995) Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 268 1347.
49. G.H. Fisher, F.J. Rosenberg, S.E. Straus, M.J. Lenardo and J.M. Puck (1995) Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 81 935.
50. J. Drappa, A.K. Vaishnaw, K.E. Sullivan, J.L. Chu and K.B. Elkon (1996) Fas gene mutations in the Canale-Smith syndrome, an inherited lymphoproliferative disorder associated with autoimmunity. N. Engl. J. Med. 335 1643.
51. J. Wang, L. Zheng, A. Lobito, F.K. Chan, J. Dale, M. Sneller, X. Yao, J.M. Puck, S.E. Straus and M.J. Lenardo (1999) Inherited human caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II. Cell 98 47.
52. E. Mysler, P. Bini, J. Drappa, P. Ramos, S.M. Friedman, P.H. Krammer and K.B. Elkon (1994) The apoptosis-1/Fas protein in human systemic lupus erythematosus. J. Clin. Invest. 93 1029.
53. J. Wu, J. Wilson, J. He, L. Xiang, P.H. Schur and J.D. Mountz (1996) Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease. J. Clin. Invest. 98 1077.
54. T. Kojima, T. Horiuchi, H. Nishizaka, T. Sawabe, M. Higuchi, S.I. Haashima, S. Yoshizawa, H. Tsukamoto, K. Nagasawa and Y. Niho (2000) Analysis of fas ligand gene mutation in patients with systemic lupus erythematosus. Arthritis Rheum. 43 135.
55. J. McNally, D.H. Yoo, J. Drappa, J.L. Chu, H. Yagita, S.M. Friedman and K.B. Elkon (1997) Fas ligand expression and function in systemic lupus erythematosus. J. Immunol. 159 4628.
56. L.D. Shultz, P.A. Schweitzer, T.V. Rajan, T. Yi, J.N. Ihle, R.J. Matthews, M.L. Thomas and D.R. Beier (1993) Mutations at the murine motheaten locus are within the hematopoietic cell protein-tyrosine phosphatase (Hcph) gene. Cell 73 1445.
57. H.W. Tsui, K.A. Siminovitch, L. deSouza and F.W.L. Tsui (1993) Motheaten and viable motheaten mice have mutations in the haematopoietic cell phosphatase gene. Nature Genet. 4 124.
58. G. Van Zant and L.D. Shultz (1989) Hematologic abnormalities of the immunodeficient mouse mutant, viable motheaten (mev ). Exp. Hematol. 17 81.
59. C.L. Scribner, C.T. Hansen, D.M. Klinman and A.D. Steinberg (1987) The interaction of the xid and me genes. J. Immunol. 138 3611.
60. C.C. Yu, H.W. Tsui, B.Y. Ngan, M.J. Shulman, G.E. Wu and F.W. Tsui (1996) B and T cells are not required for the viable motheaten phenotype. J. Exp. Med. 183 371.
61. M.L. Thomas (1995) Of ITAMs and ITIMs: Turning on and off the B cell antigen receptor. J. Exp. Med. 181 1953.
62. G.M. Doody, L.B. Justement, C.C. Delibrias, R.J. Matthews, J. Lin, M.L. Thomas and D.T. Fearon (1995) A role in B cell activation for CD22 and the protein tyrosine phosphatase SHP. Science 269 242.
63. E.D. Murphy and J.B. Roths (1979) A Y chromosome associated factor in strain BXSB producing accelerated autoimmunity and lymphoproliferation. Arthritis Rheum. 22 1188.
64. R.A. Eisenberg, S. Izui, P.J. McConahey, L.M. Hang, C.J. Peters, A.N. Theofilopoulos and F.J. Dixon (1980) Male determined accelerated autoimmune disease in BXSB mice: Transfer by bone marrow and spleen cells. J. Immunol. 125 1032.
65. S. Izui, M. Iwamoto, L. Fossati, R. Merino, S. Takahashi and N. Ibnou-Zekri (1995) The Yaa gene model of systemic lupus erythematosus. Immunol. Rev. 144 137.
66. C.C. Hudgins, R.T. Steinberg, D.M. Klinman, M.J.P. Reeves, A.D. Steinberg and M.J. Reeves (1985) Studies of consomic mice bearing the Y chromosome of the BXSB mouse. J. Immunol. 134 3849.
67. S. Izui, M. Higaki, D. Morrow and R. Merino (1988) The Y chromosome from autoimmune BXSB/MpJ mice induces a lupus-like syndrome in (NZW x C57BL/6)F1 male mice, but not in C57BL/6 male mice. Eur. J. Immunol. 18 911.
68. R. Merino, T. Shibata, S. de Kossodo and S. Izui (1989) Differential effect of the autoimmune Yaa and Ipr genes on the acceleration of lupus-like syndrome in MRL/MpJ mice. Eur. J. Immunol. 19 2131.
69. H. Suzuka, H. Yoshifusa, Y. Nakamura, S. Miyawaki and Y. Shibata (1993) Morphological analysis of autoimmune disease in MRL-Ipr,Yaa male mice with rapidly progressive systemic lupus erythematosus. Autoimmunity 14 275.
70. L. Jansson and R. Holmdahl (1994) The Y chromosome-linked “autoimmune accelerating” yaa gene suppresses collagen-induced arthritis. Eur. J. Immunol. 24 1213.
71. R. Merino, L. Fossati, M. Lacour and S. Izui (1991) Selective autoantibody production by Yaa+ B cells in autoimmune Yaa+-Yaa− bone marrow chimeric mice. J. Exp. Med. 174 1023.
72. L. Fossati, M. Iwamoto, R. Merino and S. Izui (1995) Selective enhancing effect of the Yaa gene on immune responses against self and foreign antigens. Eur. J. Immunol. 25 166.
73. A.W. Hugin, L. Fossati-Jimack and S. Izui (2000) The autoimmune accelerating yaa mutation does not accelerate murine AIDS. Cell. Immunol. 200 76.
74. L. Fossati, E.S. Sobel, M. Iwamoto, P.L. Cohen, R.A. Eisenberg and S. Izui (1995) The Yaa gene-mediated acceleration of murine lupus: Yaa −T cells from non-autoimmune mice collaborate with Yaa+ B cells to produce lupus autoantibodies in vivo. Eur. J. Immunol. 25 3412.
75. B.R. Lawson, S. Koundouris, M. Barnhouse, W. Dummer, R. Baccala, D.H. Kono and A.N. Theofilopoulos (2001) The role of ab+T cells and homeostatic T cell proliferation in Yaa+-associated murine lupus. J. Immunol. 167 2354.
76. L.E. DesJardin, E.J. Butfiloski, E.S. Sobel and J. Schiffenbauer (1996) Hyperproli feration of BXSB B cells is linked to the Yaa allele. Clin. Immunol. Immunopathol. 81 145.
77. A. Darvasi (1998) Experimental strategies for the genetic dissection of complex traits in animal models. Nature Genet. 18 19.
78. D.H. Kono, R.W. Burlingame, D.G. Owens, A. Kuramochi, R.S. Balderas, D. Balomenos and A.N. Theofilopoulos (1994) Lupus susceptibility loci in New Zealand mice. Proc. Natl. Acad. Sci. USA 91 10168.
79. T.J. Vyse and B.L. Kotzin (1998) Genetic susceptibility to systemic lupus erythematosus. Annu. Rev. Immunol. 16 261.
80. L. Morel and E.K. Wakeland (1998) Susceptibility to lupus nephritis in the NZB/W model system. Curr. Opin. Immunol. 10 718.
81. L. Morel, C. Mohan, Y. Yu, B.P. Croker, N. Tian, A. Deng and E.K. Wakeland (1997) Functional dissection of systemic lupus erythematosus using congenic mouse strains. J. Immunol. 158 6019.
82. L. Morel, Y. Yu, K.R. Blenman, R.A. Caldwell and E.K. Wakeland (1996) Production of congenic mouse strains carrying genomic intervals containing SLE-susceptibility genes derived from the SLE-prone NZM2410 strain. Mamm. Genome 7 335.
83. C. Mohan, E. Alas, L. Morel, P. Yang and E.K. Wakeland (1998) Genetic dissection of SLE pathogenesis: Sle1 on murine chromosome 1 leads to a selective loss of tolerance to H2A/H2B/DNA subnucleosomes. J. Clin. Invest. 101 1362.
84. E.S. Sobel, C. Mohan, L. Morel, J. Schiffenbauer and E.K. Wakeland (1999) Genetic dissection of SLE pathogenesis: A doptive transfer of Sle1 mediates the loss of tolerance by bone marrow-derived B cells. J. Immunol. 162 2415.
85. C. Mohan, L. Morel, P. Yang and E.K. Wakeland (1997) Genetic dissection of systemic lupus erythematosus pathogenesis: Sle2 on murine chromosome 4 leads to B cell hyperactivity. J. Immunol. 159 454.
86. C. Mohan, L. Morel, P. Yang and E.K. Wakeland (1998) Accumulation of splenic B1a cells with potent antigen-presenting capability in NZM2410 lupus-prone mice. Arthritis Rheum. 41 1652.
87. C. Mohan, Y. Yu, L. Morel, P. Yang and E.K. Wakeland (1999) Genetic dissection of Sle pathogenesis: Sle3 on murine chromosome 7 impacts T cell activation, differentiation, and cell death. J. Immunol. 162 6492.
88. L. Morel, C. Mohan, Y. Yu, J. Schiffenbauer, U.H. Rudofsky, N. Tian, J.A. Longmate and E.K. Wakeland (1999) Multiplex inheritance of component phenotypes in a murine model of lupus. Mamm. Genome 10 176.
89. C. Mohan, L. Morel, P. Yang, H. Watanabe, B. Croker, G. Gilkeson and E.K. Wakeland (1999) Genetic dissection of lupus pathogenesis: A recipe for nephrophilic autoantibodies. J. Clin. Invest. 103 1685.
90. L. Morel, B.P. Croker, K.R. Blenman, C. Mohan, G. Huang, G. Gilkeson and E.K. Wakeland (2000) Genetic reconstitution of systemic lupus erythematosus immunopathology with polycongenic murine strains. Proc. Natl. Acad. Sci. USA 97 6670.
91. L. Morel, K.R. Blenman, B.P. Croker and E.K. Wakeland (2001) The major murine systemic lupus erythmatosus susceptibility locus, Sle1, is a cluster of functionally related genes. Proc. Natl. Acad. Sci. USA 98 1787.
92. S.A. Boackle, V.M. Holers, X. Chen, G. Szakonyi, D.R. Karp, E.K. Wakeland and L. Morel (2001) Cr2, a candidate gene in the murine Sle1c lupus susceptibility locus, encodes a dysfunctional protein. Immunity 15 775.
93. D.T. Fearon and M.C. Carroll (2000) Regulation of B lymphocyte responses to foreign and self-antigens by the CD19/CD21 complex. Annu. Rev. Immunol. 18 393.
94. A.P. Prodeus, S. Goerg, L.M. Shen, O.O. Pozdnyakova, L. Chu, E.M. Alicot, C.C. Goodnow and M.C. Carroll (1998) A critical role for complement in maintenance of self-tolerance. Immunity 9 721.
95. X. Wu, N. Jiang, C. Deppong, J. Singh, G. Dolecki, D. Mao, L. Morel and H.D. Molina (2002) A role for the Cr2 gene in modifying autoantibody production in systemic lupus erythematosus. J. Immunol. 169 1587.
96. H.V. Marquart, A. Svendsen, J.M. Rasmussen, C.H. Nielsen, P. Junker, S.E. Svehag and R.G. Leslie (1995) Complement receptor expression and activation of the complement cascade on B lymphocytes from patients with systemic lupus erythematosus (SLE). Clin. Exp. Immunol. 101 60.
97. S.J. Rozzo, J.D. Allard, D. Choubey, T.J. Vyse, S. Izui, G. Peltz and B.L. Kotzin (2001) Evidence for an interferon-inducible gene, Ifi202, in the susceptibility to systemic lupus. Immunity 15 435.
98. D. Choubey and B.L. Kotzin (2002) Interferon-inducible p202 in the susceptibility to systemic lupus. Front. Biosci. 7 e252.
99. Y. Jiang, S. Hirose, R. Sanokawa-Akakura, M. Abe, X. Mi, N. Li, Y. Miura, J. Shirai, D. Zhang, Y. Hamano and T. Shirai (1999) Genetically determined aberrant down-regulation of FegammaRIIB1 in germinal center B cells associated with hyper-IgG and IgG autoantibodies in murine systemic lupus erythematosus. Int. Immunol. 11 1685.
100. C. Mary, C. Laporte, D. Parzy, M.L. Santiago, F. Stefani, F. Lajaunias, R.M. Parkhouse, T.L. O'Keefe, M.S. Neuberger, S. Izui and L. Reininger (2000) Dys-regulated expression of the Cd22 gene as a result of a short interspersed nucleotide element insertion in Cd22a lupus-prone mice. J. Immunol. 165 2987.
101. S. Vidal, D.H. Kono and A.N. Theofilopoulos (1998) Loci predisposing to autoimmunity in MRL-FasIpr and C57BL/6-FasIpr mice. J. Clin. Invest. 101 696.
102. Y. Wang, M. Nose, T. Kamoto, M. Nishimura and H. Hiai (1997) Host modifier genes affect mouse autoimmunity induced by the Ipr gene. Am. J. Pathol. 151 1791.
103. M.L. Watson, J.K. Rao, G.S. Gilkeson, P. Ruiz, E.M. Eicher, D.S. Pisetsky, A. Matsuzawa, J.M. Rochelle and M.F. Seldin (1992) Genetic analysis of MRL-Ipr mice: Relationship of the Fas apoptosis gene to disease manifestations and renal disease-modifying loci. J. Exp. Med. 176 1645.
104. M. Nishihara, M. Terada, J. Kamogawa, Y. Ohashi, S. Mori, S. Nakatsuru, Y. Nakamura and M. Nose (1999) Genetic basis of autoimmune sialadenitis in MRL/Ipr lupus-prone mice: Additive and hierarchical properties of polygenic inheritance. Arthritis Rheum. 42 2616.
105. J.R. Parnes and C. Pan (2000) CD72, a negative regulator of B-cell responsiveness. Immunol. Rev. 176 75.
106. W. Qu, T. Miyazaki, M. Terada, L. Lu, M. Nishihara, A. Yamada, S. Mori, Y. Nakamura, H. Ogasawara, C. Yazawa, S. Nakatsuru and M. Nose (2000) Genetic dissection of vasculitis in MRL/Ipr lupus mice: A novel susceptibility locus involving the CD72c allele. Eur. J. Immunol. 30 2027.
107. M.B. Hogarth, J.H. Slingsby, P.J. Allen, E.M. Thompson, P. Chandler, K.A. Davies, E. Simpson, B.J. Morley and M.J. Walport (1998) Multiple lupus susceptibility loci map to chromosome 1 in BXSB mice. J. Immunol. 161 2753.
108. M.E. Haywood, M.B. Hogarth, J.H. Slingsby, S.J. Rose, P.J. Allen, E.M. Thompson, M.A. Maibaum, P. Chandler, K.A. Davies, E. Simpson, M.J. Walport and B.J. Morley (2000) Identification of intervals on chromosomes 1,3, and 13 linked to the development of lupus in BXSB mice. Arthritis Rheum. 43 349.
109. A. Ida, S. Hirose, Y. Hamano, S. Kodera, Y. Jiang, M. Abe, D. Zhang, H. Nishimura and T. Shirai (1998) Multigenic control of lupus-associated antiphospholipid syndrome in a model of (NZW x BXSB) F1 mice. Eur. J. Immunol. 28 2694.
110. H. Nishizumi, I. Taniuchi, Y. Yamanashi, D. Kitamura, D. Ilic, S. Mori, T. Watanabe and T. Yamamoto (1995) Impaired proliferation of peripheral B cells and indication of autoimmune disease in lyn-deficient mice. Immunity 3 549.
111. M.L. Hibbs, D.M. Tarlinton, J. Armes, D. Grail, G. Hodgson, R. Maglitto, S.A. Stacker and A.R. Dunn (1995) Multiple defects in the immune system of Lyn-deficient mice, culminating in autoimmune disease. Cell 83 301.
112. T.L. O'Keefe, G.T. Williams, S.L. Davies and M.S. Neuberger (1996) Hyperresponsive B cells in CD22-deficient mice. Science 274 798.
113. K.L. Otipoby, K.B. Andersson, K.E. Draves, S.J. Klaus, A.G. Carr, J.D. Kerner, R.M. Perlmutter, C.L. Law and E.A. Clark (1996) CD22 regulates thymus-independent responses and the lifespan of B cells. Nature 384 634.
114. S. Sato, A.S. Miller, M. Inaoki, C.B. Bock, P.J. Jansen, M.L.K. Tang and T.F. Tedder (1996) CD22 is both a positive and negative regulator of B lymphocyte antigen receptor signal transduction: Altered signaling in CD 22 deficient mice. Immunity 5 551.
115. R.J. Cornall, J.G. Cyster, M.L. Hibbs, A.R. Dunn, K.L. Otipoby, E.A. Clark and C.C. Goodnow (1998) Polygenic autoimmune traits: Lyn, CD22, and SHP-1 are limiting elements of a biochemical pathway regulating BCR signaling and selection. Immunity 8 497.
116. T.F. Tedder, M. Inaoki and S. Sato (1997) The CD19-CD21 complex regulates signal transduction thresholds governing humoral immunity and autoimmunity. Immunity 6 107.
117. M. Inaoki, S. Sato, B.C. Weintraub, C.C. Goodnow and T.F. Tedder (1997) CD19-regulated signaling thresholds control peripheral tolerance and autoantibody production in B lymphocytes. J. Exp. Med. 186 1923.
118. K.M. Coggeshall (1998) Inhibitory signaling by B cell Fc gamma RIIb. Curr. Opin. Immunol. 10 306.
119. M. Ono, H. Okada, S. Bolland, S. Yanagi, T. Kurosaki and J.V. Ravetch (1997) Deletion of SHIP or SHP-1 reveals two distinct pathways for inhibitory signaling. Cell 90 293.
120. M.J.S. Nadler, B. Chen, J.S. Anderson, H.H. Wortis and B.G. Neel (1997) Protein-tyrosine phosphatase SHP-1 is dispensable for FegammaRIIB-mediated inhibition of B cell antigen receptor activation. J. Biol. Chem. 272 20038.
121. T. Takai, M. Ono, M. Hikida, H. Ohmori and J.V. Ravetch (1996) Augmented humoral and anaphylactic responses in FcgRII-deficient mice. Nature 379 346.
122. S. Bolland and J.V. Ravetch (2000) Spontaneous autoimmune disease in Fc(gamma)RIIB-deficient mice results from strain-specific epistasis. Immunity 13 277.
123. T. Yuasa, S. Kubo, T. Yoshino, A. Ujike, K. Matsumura, M. Ono, J.V. Ravetch and T. Takai (1999) Deletion of fegamma receptor IIB renders H-2(b) mice susceptible to collagen-induced arthritis. J. Exp. Med. 189 187.
124. A. Nakamura, T. Yuasa, A. Ujike, M. Ono, T. Nukiwa, J.V. Ravetch and T. Takai (2000) Fcg Receptor IIB-deficient mice develop Goodpasture's syndrome upon immunization with type IV collagen: A novel murine model for autoimmune glomerular basement membrane disease. J. Exp. Med. 191 899.
125. S. Bolland, Y.S. Yim, K. Tus, E.K. Wakeland and J.V. Ravetch (2002) Genetic modifiers of systemic lupus erythematosus in FcgammaRIIB(−/−) mice. J. Exp. Med. 195 1167.
126. B. Morgan, L. Sun, N. Avitahl, K. Andrikopoulos, T. Ikeda, E. Gonzales, P. Wu, S. Neben and K. Georgopoulos (1997) Aiolos, a lymphoid restricted transcription factor that interacts with Ikaros to regulate lymphocyte differentiation. EMBO J. 16 2004.
127. Y. Xue, J. Wong, G.T. Moreno, M.K. Young, J. Cote and W. Wang (1998) NURD, a novel complex with both ATP-dependent chromatin-remodeling and histone deacetylase activities. Mol. Cell. 2 851.
128. Y. Zhang, H.H. Ng, H. Erdjument-Bromage, P. Tempst, A. Bird and D. Reinberg (1999) Analysis of the NuRD subunits reveals a histone deacetylase core complex and a connection with DNA methylation. Genes Dev. 13 1924.
129. P.S. Knoepfler and R.N. Eisenman (1999) Sin meets NuRD and other tails of repression. Cell 99 447.
130. J. Koipally, A. Renold, J. Kim and K. Georgopoulos (1999) Repression by Ikaros and Aiolos is mediated through histone deacetylase complexes. EMBO J. 18 3090.
131. J.H. Wang, N. Avitahl, A. Cariappa, C. Friedrich, T. Ikeda, A. Renold, K. Andrikopoulos, L. Liang, S. Pillai, B.A. Morgan and K. Georgopoulos (1998) Aiolos regulates B cell activation and maturation to effector state. Immunity 9 543.
132. P.A. Moore, O. Belvedere, A. Orr, K. Pieri, D.W. LaFleur, P. Feng, D. Soppet, M. Charters, R. Gentz, D. Parmelee, Y. Li, O. Galperina, J. Giri, V. Roschke, B. Nardelli, J. Carrell, S. Sosnovtseva, W. Greenfield, S.M. Ruben, H.S. Olsen, J. Fikes and D.M. Hilbert (1999) BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator. Science 285 260.
133. P. Schneider, F. MacKay, V. Steiner, K. Hofmann, J.L. Bodmer, N. Holler, C. Ambrose, P. Lawton, S. Bixler, H. Acha-Orbea, D. Valmori, P. Romero, C. Werner-Favre, R.H. Zubler, J.L. Browning and J. Tschopp (1999) BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth. J. Exp. Med. 189 1747.
134. H.B. Shu, W.H. Hu and H. Johnson (1999) TALL-1 is a novel member of the TNF family that is down-regulated by mitogens. J. Leukocyte Biol. 65 680.
135. A. Mukhopadhyay, J. Ni, Y. Zhai, G.L. Yu and B.B. Aggarwal (1999) Identification and characterization of a novel cytokine, THANK, a TNF homologue that activates apoptosis, nuclear factor-kappaB, and c-Jun NH2-terminal kinase. J. Biol. Chem. 274 15978.
136. J.A. Gross, J. Johnston, S. Mudri, R. Enselman, S.R. Dillon, K. Madden, X. Wenfeng, J. Parrish-Novak, D. Foster, C. Lofton-Day, M. Moore, A. Littau, A. Grossman, H. Haugen, K. Foley, H. Blumberg, K. Harrison, W. Kindsvogel and C.H. Clegg (2000) TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease. Nature 404 995.
137. F. Mackay, S.A. Woodcock, P. Lawton, C. Ambrose, M. Baetscher, P. Schneider, J. Tschopp and J.L. Browning (1999) Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations. J. Exp. Med. 190 1697.
138. S.D. Khare, I. Sarosi, X.Z. Xia, S. McCabe, K. Miner, I. Solovyev, N. Hawkins, M. Kelley, D. Chang, G. Van, L. Ross, J. Delaney, L. Wang, D. Lacey, W.J. Boyle and H. Hsu (2000) Severe B cell hyperplasia and autoimmune disease in TALL-1 transgenic mice. Proc. Natl. Acad. Sci. USA 97 3370.
139. I. Mecklenbrauker, K. Saijo, N.Y. Zheng, M. Leitges and A. Tarakhovsky (2002) Protein kinase C delta controls self-antigen-induced B-cell tolerance. Nature 416 860.
140. A. Miyamoto, K. Nakayama, H. Imaki, S. Hirose, Y. Jiang, M. Abe, T. Tsukiyama, H. Nagahama, S. Ohno, S. Hatakeyama and K.I. Nakayama (2002) Increased proliferation of B cells and auto-immunity in mice lacking protein kinase C delta. Nature 416 865.
141. L. Zhang, A. Eddy, Y.T. Teng, M. Fritzler, M. Kluppel, F. Melet and A. Bernstein (1995) An immunological renal disease in transgenic mice that overexpress Fli-1, a member of the ets family of transcription factor genes. Mol. Cell. Biol. 15 6961.
142. T. Higuchi, Y. Aiba, T. Nomura, J. Matsuda, K. Mochida, M. Suzuki, H. Kikutani, T. Honjo, K. Nishioka and T. Tsubata (2002) Cutting edge: Ectopic expression of CD40 ligand on B cells induces lupus-like autoimmune disease. J. Immunol. 168 9.
143. C. van Kooten and J. Banchereau (2000) CD40-CD40 ligand. J. Leukocyte Biol. 67 2.
144. A. Desai-Mehta, L. Lu, R. Ramsey-Goldman and S.K. Datta (1996) Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production. J. Clin. Invest. 97 2063.
145. M. Koshy, D. Berger and M.K. Crow (1996) Increased expression of CD40 ligand on systemic lupus erythematosus lymphocytes. J. Clin. Invest. 98 826.
146. S. Blossom, E.B. Chu, W.O. Weigle and K.M. Gilbert (1997) CD40 ligand expressed on B cells in the BXSB mouse model of systemic lupus erythematosus. J. Immunol. 159 4580.
147. P. Waterhouse, J.M. Penninger, E. Timms, A. Wakeham, A. Shahinian, K.P. Lee, C.B. Thompson, H. Griesser and T.W. Mak (1995) Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science 270 985.
148. E.A. Tivol, F. Borriello, A.N. Schweitzer, W.P. Lynch, J.A. Bluestone and A.H. Sharpe (1995) Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 3 541.
149. E.A. Tivol, S.D. Boyd, S. McKeon, F. Borriello, P. Nickerson, T.B. Strom and A.H. Sharpe (1997) CTLA4 Ig prevents lymphoproliferation and fatal multiorgan tissue destruction in CTLA-4-deficient mice. J. Immunol. 158 5091.
150. C.A. Chambers, D. Cado, T. Truong and J.P. Allsion (1997) Thymocyte development is normal in CTLA-4-deficient mice. Proc. Natl. Acad. Sci. USA 94 9296.
151. C.A. Chambers, T.J. Sullivan and J.P. Allison (1997) Lymphoproliferation in CTLA-4-deficient mice is mediated by costimulation-dependent activation of CD4+ T cells. Immunity 7 885.
152. C.A. Chambers, M.S. Kuhns and J.P. Allison (1999) Cytotoxic T lymphocyte antigen-4 (CTLA-4) regulates primary and secondary peptide-specific CD4(+) T cell responses. Proc. Natl. Acad. Sci. USA 96 8603.
153. M.F. Bachmann, G. Kohler, B. Ecabert, T.W. Mak and M. Kopf (1999) Cutting edge: Lymphoproliferative disease in the absence of CTLA-4 is not T cell autonomous. J. Immunol. 163 1128.
154. H. Schorle, T. Holtschke, T. Hunig, A. Schimpl and I. Horak (1991) Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting. Nature 352 621.
155. T.M. Kundig, H. Schorle, M.F. Bachmann, H. Hengartner, R.M. Zinkernagel and I. Horak (1993) Immune responses in interleukin-2-deficient mice. Science 262 1059.
156. B. Sadlack, J. Lohler, H. Schorle, G. Klebb, H. Haber, E. Sickel, R.J. Noelle and I. Horak (1995) Generalized autoimmune disease in interleukin-2-deficient mice is triggered by an uncontrolled activation and proliferation of CD4+ T cells. Eur. J. Immunol. 25 3053.
157. D.M. Willerford, J. Chen, J.A. Ferry, L. Davidson, A. Ma and F.W. Alt (1995) Interleukin-2 receptor alpha chain regulates the size and content of the peripheral lymphoid compartment. Immunity 3 521.
158. H. Suzuki, T.M. Kundig, C. Furlonger, A. Wakeham, E. Timms, T. Matsuyama, R. Schmits, J.J.L. Simard, P.S. Ohashi, H. Griesser, T. Taniguchi, C.J. Paige and T.W. Mak (1995) Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor. Science 268 1472.
159. B. Sadlack, H. Merz, H. Schorle, A. Schimpl, A.C. Feller and I. Horak (1993) Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 75 253.
160. L. Van Parijs, A. Biuckians, A. Ibragimov, F.W. Alt, D.M. Willerford and A.K. Abbas (1997) Functional responses and apoptosis of CD25 (IL-2R alpha)-deficient T cells expressing a transgenic antigen receptor. J. Immunol. 158 3738.
161. N.V. Contractor, H. Bassiri, T. Reya, A.Y. Park, D.C. Baumgart, M.A. Wasik, S.G. Emerson and S.R. Carding (1998) Lymphoid hyperplasia, autoimmunity, and compromised intestinal intraepithelial lymphocyte development in colitis-free gnotobiotic IL-2-deficient mice. J. Immunol. 160 385.
162. M.M. Shull, I. Ormsby, A.B. Kier, S. Pawlowski, R.J. Diebold, M. Yin, R. Allen, C. Sidman, G. Proetzel, D. Calvin, N. Annunziata and T. Doetschman (1992) Trageted disruption of the mouse transforming growth factor-1 gene results in multifocal inflammatory disease. Nature 359 693.
163. A.B. Kulkarni and S. Karlsson (1993) Transforming growth factor-beta 1 knockout mice: A mutation in one cytokine gene causes a dramatic inflammatory disease. Am. J. Pathol. 143 3.
164. H. Dang, A.G. Geiser, J.J. Letterio, T. Nakabayashi, L. Kong, G. Fernandes and N. Talal (1995) SLE-like autoantibodies and Sjögren's syndrome-like lymphoproliferation in TGF-knockout mice. J. Immunol. 155 3205.
165. J.J. Letterio, A.G. Geiser, A.B. Kulkarni, H. Dang, L. Kong, T. Nakabayashi, C.L. Mackall, R.E. Gress and A.B. Roberts (1996) Autoimmunity associated with TGF-betal-deficiency in mice is dependent on MHC class II antigen expression. J. Clin. Invest. 98 2109.
166. S. Kobayashi, K. Yoshida, J.M. Ward, J.J. Letterio, G. Longenecker, L. Yaswen, B. Mittleman, E. Mozes, A.B. Roberts, S. Karlsson and A.B. Kulkarni (1999) Beta 2-microglobulin-deficient background ameliorates lethal phenotype of the TGF-beta 1 null mouse. J. Immunol. 163 4013.
167. L. Gorelik and R.A. Flavell (2000) Abrogation of TGFbeta signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease. Immunity 12 171.
168. M.J. Lupher Jr., N. Rao, M.J. Eck and H. Band (1999) The Cbl protooncoprotein: A negative regulator of immune receptor signal transduction. Immunol. Today 20 375.
169. M.M. Keane, O.M. Rivero-lezcano, J.A. Mitchell, K.C. Robbins and S. Lipkowitz (1995) Cloning and characterization of cbl-b: A SH3 binding protein with homology to the c-cbl protooncogene. Oncogene 10 2367.
170. M.M. Keane, S.A. Ettenberg, M.M. Nau, P. Banerjee, M. Cuello, J. Penninger and S. Lipkowitz (1999) cbl-3: A new mammalian cbl family protein. Oncogene 18 3365.
171. M. Kim, T. Tezuka, Y. Suziki, S. Sugano, M. Hirai and T. Yamamoto (1999) Molecular cloning and characterization of a novel cbl-family gene, cbl-c. Gene 239 145.
172. J.L. Clements, N.J. Boerth, J.R. Lee and G.A. Koretzky (1999) Integration of T cell receptor-dependent signaling pathways by adapter proteins. Annu. Rev. Immunol. 17 89.
173. C.E. Rudd (1999) Adaptors and molecular scaffolds in immune cell signaling. Cell 96 5.
174. Y.J. Chiang, H.K. Kole, K. Brown, M. Naramura, S. Fukuhara, R.J. Hu, I.K. Jang, J.S. Gutkind, E. Shevach and H. Gu (2000) Cbl-b regulates the CD28 dependence of T-cell activation. Nature 403 216.
175. K. Bachmaier, C. Krawczyk, I. Kozieradzki, Y.Y. Kong, T. Sasaki, A. Oiveira-dos-Santos, S. Mariathasan, D. Bouchard, A. Wakeham, A. Itie, J. Le, P.S. Ohashi, I. Sarosi, H. Nishina, S. Lipkowitz and J.M. Penninger (2000) Negative regulation of lymphocyte activation and autoimmunity by the molecular adaptor Cbl-b. Nature 403 211.
176. X.R. Bustelo, P. Crespo, M. Lopez-Barahona, J.S. Gutkind and M. Barbacid (1997) Cbl-b, a member of the Sli-1/c-Cbl protein family, inhibits Vav- mediated c-Jun N-terminal kinase activation. Oncogene 15 2511.
177. K. Kishihara, J. Penninger, V.A. Wallace, T.M. Kundig, K. Kawai, A. Wakeham, E. Timms, K. Pfeffer, P.S. Ohashi, M.L. Thomas, et al. (1993) Normal B lymphocyte development but impaired T cell maturation in CD45-exo n6 protein tyrosine phosphatase-deficient mice. Cell 74 143.
178. K.F. Byth, L.A. Conroy, S. Howlett, A.J. Smith, J. May, D.R. Alexander and N. Holmes (1996) CD45-null transgenic mice reveal a positive regulatory role for CD45 in early thymocyte development, in the selection of CD4+CD8+ thymocytes, and B cell maturation. J. Exp. Med. 183 1707.
179. C.M. Cale, N.J. Klein, V. Novelli, P. Veys, A.M. Jones and G. Morgan (1997) Severe combined immunodeficiency with abnormalities in expression of the common leucocyte antigen, CD45. Arch. Dis. Child. 76 163.
180. A.M. Bilwes, J. den Hertog, T. Hunter and J.P. Noel (1996) Structural basis for inhibition of receptor protein-tyrosine phosphatase-alpha by dimerization. Nature 382 555.
181. R. Majeti, Z. Xu, T.G. Parslow, J.L. Olson, D.L. Daikh, N. Killeen and A. Weiss (2000) An inactivating point mutation in the inhibitory wedge of CD45 causes lymphoproliferation and autoimmunity. Cell 103 1059.
182. Y. Ishida, Y. Agata, K. Shibahara and T. Honjo (1992) Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death. EMBO. J. 11 3887.
183. H. Nishimura, N. Minato, T. Nakano and T. Honjo (1998) Immunological studies on PD-1 deficient mice: Implication of PD-1 as a negative regulator for B cell responses. Int. Immunol. 10 1563.
184. H. Nishimura, M. Nose, H. Hiai, N. Minato and T. Honjo (1999) Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. Immunity 11 141.
185. W. Fan, G. Richter, A. Cereseto, C. Beadling and K.A. Smith (1999) Cytokine response gene 6 induces p21 and regulates both cell growth and arrest. Oncogene 18 6573.
186. M. Vairapandi, A.G. Balliet, A.J. Fornace Jr., B. Hoffman and D.A. Liebermann (1996) The differentiation primary response gene MyD118, related to GADD45, encodes for a nuclear protein which interacts with PCNA and p21WAF1/CIP1. Oncogene 12 2579.
187. J.M. Salvador, M.C. Hollander, A.T. Nguyen, J.B. Kopp, L. Barisoni, J.K. Moore, J.D. Ashwell and A.J. Fornace Jr. (2002) Mice lacking the p53-effector gene Gadd45a develop a lupus-like syndrome. Immunity 16 499.
188. D. Yablonski and A. Weiss (2001) Mechanisms of signaling by the hematopoietic-specific adaptor proteins, SLP-76 and LAT and their B cell counterpart, BLNK/SLP-65. Adv. Immunol. 79 93.
189. C.L. Sommers, C.S. Park, J. Lee, C. Feng, C.L. Fuller, A. Grinberg, J.A. Hildebrand, E. Lacana, R.K. Menon, E.W. Shores, L.E. Samelson and P.E. Love (2002) A LAT mutation that inhibits T cell development yet induces lymphoproliferation. Science 296 2040.
190. M.T. Aguado, R.S. Balderas, R.L. Rubin, M.A. Duchosal, R. Kofler, B.K. Birshtein, D.S. Secher, F.J. Dixon and A.N. Theofilopoulos (1987) Specificity and molecular characteristics of monoclonal IgM rheumatoid factors from arthritic and non-arthritic mice. J. Immunol. 139 1080.
191. L.Q. Le, J.H. Kabarowski, Z. Weng, A.B. Satterthwaite, E.T. Harvill, E.R. Jensen, J.F. Miller and O.N. Witte (2001) Mice lacking the orphan G protein-coupled receptor G2A develop a late-onset autoimmune syndrome. Immunity 14 561.
192. G.S. Vratsanos, S. Jung, Y.M. Park and J. Craft (2001) CD4(+) T cells from lupus-prone mice are hyperresponsive to T cell receptor engagement with low and high affinity peptide antigens: A model to explain spontaneous T cell activation in lupus. J. Exp. Med. 193 329.
193. L. O'Connor, A. Strasser, L.A. O'Reilly, G. Hausmann, J.M. Adams, S. Cory and D.C. Huang (1998) Bim: A novel member of the Bcl-2 family that promotes apoptosis. EMBO J. 17 384.
194. H. Puthalakath, D.C. Huang, L.A. O'Reilly, S.M. King and A. Strasser (1999) The proapoptotic activity of the Bcl-2 family member Bim is regulated by interaction with the dynein motor complex. Mol. Cell. 3 287.
195. P. Bouillet, D. Metcalf, D.C. Huang, D.M. Tarlinton, T.W. Kay, F. Kontgen, J.M. Adams and A. Strasser (1999) Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. Science 286 1735.
196. A. Strasser, S. Whittingham, D.L. Vaux, M.L. Bath, J.M. Adams, S. Cory and A.W. Harris (1991) Enforced bcl-2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease. Proc. Natl. Acad. Sci. USA 88 8661.
197. S.K. Ray, C. Putterman and B. Diamond (1996) Pathogenic autoantibodies are routinely generated during the response to foreign antigen: A paradigm for autoimmune disease. Proc. Natl. Acad. Sci. USA 93 2019.
198. P. Kuo, M. Bynoe and B. Diamond (1999) Crossreactive B cells are present during a primary but not secondary reponse in BALB/c mice expressing a bcl-2 transgene. Mol. Immunol. 36 471.
199. L. Mandik-Nayak, S. Nayak, C. Sokol, A. Eaton-Bassiri, M.P. Madaio, A.J. Caton and J. Erikson (2000) The origin of anti-nuclear antibodies in bcl-2 transgenic mice. Int. Immunol. 12 353.
200. L.C. Cantley and B.G. Neel (1999) New insights into tumor suppression PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. Proc. Natl. Acad. Sci. USA 96 4240.
201. A. Di Cristofano and P.P. Pandolfi (2000) The multiple roles of PTEN in tumor suppression. Cell 100 387.
202. A. Di Cristofano, P. Kotsi, Y.F. Peng, C. Cordon-Cardo, K.B. Elkon and P.P. Pandolfi (1999) Impaired Fas response and autoimmunity in Pten+/- mice. Science 285 2122.
203. T. Maehama and J.E. Dixon (1998) The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J. Biol. Chem. 273 13375.
204. M. Irmler, M. Thome, M. Hahne, P. Schneider, K. Hofmann, V. Steiner, J.L. Bodmer, M. Schroter, K. Burns, C. Mattmann, D. Rimoldi, L.E. French and J. Tschopp (1997) Inhibition of death receptors signals by cellular FLIP. Nature 388 190.
205. J. Tschopp, M. Irmler and M. Thome (1998) Inhibition of fas death signals by FLIPs. Curr. Opin. Immunol. 10 552.
206. L. Van Parijs, Y. Refaeli, A.K. Abbas and D. Baltimore (1999) Autoimmunity as a consequence of retrovirus-mediated expression of C-FLIP in lymphocytes. Immunity 11 763.
207. H.J. Im, M.R. Pittelkow and R. Kumar (2002) Divergent regulation of the growth-promoting gene IEX-1 by the p53 tumor suppressor and Sp1. J. Biol. Chem. 277 14612.
208. Q. Lu and G. Lemke (2001) Homeostatic regulation of the immune system by receptor tyrosine kinases of the Tyro 3 family. Science 293 306.
209. P.L. Schwartzberg (2001) Immunology: Tampering with the immune system. Science 293 228.
210. Q. Lu, M. Gore, Q. Zhang, T. Camenisch, S. Boast, F. Casagranda, C. Lai, M.K. Skinner, R. Klein, G.K. Matsushima, H.S. Earp, S.P. Goff and G. Lemke (1999) Tyro-3 family receptors are essential regulators of mammalian spermatogenesis. Nature 398 723.
211. R.S. Scott, E.J. McMahon, S.M. Pop, E.A. Reap, R. Caricchio, P.L. Cohen, H.S. Earp and G.K. Matsushima (2001) Phagocytosis and clearance of apoptotic cells is mediated by MER. Nature 411 207.
212. P.L. Cohen, R. Caricchio, V. Abraham, T.D. Camenisch, J.C. Jennette, R.A. Roubey, H.S. Earp, G. Matsushima and E.A. Reap (2002) Delayed apoptotic cell clearance and lupus-like autoimmunity in mice lacking the c-mer membrane tyrosine kinase. J. Exp. Med. 196 135.
213. A. Mehling, K. Loser, G. Varga, D. Metze, T.A. Luger, T. Schwarz, S. Grabbe and S. Beissert (2001) Overexpression of CD40 ligand in murine epidermis results in chronic skin inflammation and systemic autoimmunity. J. Exp. Med. 194 615.
214. J.P. Seery, J.M. Carroll, V. Cattell and F.M. Watt (1997) Antinuclear autoantibodies and lupus nephritis in transgenic mice expressing interferon gamma in the epidermis. J. Exp. Med. 186 1451.
215. M. Botto, C. Dell'Agnola, A.E. Bygrave, E.M. Thompson, H.T. Cook, F. Petry, M. Loos, P.P. Pandolfi and M.J. Walport (1998) Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nature Genet. 19 56.
216. M.C. Bickerstaff, M. Botto, W.L. Hutchinson, J. Herbert, G.A. Tennent, A. Bybee, D.A. Mitchell, H.T. Cook, P.J. Butler, M.J. Walport and M.B. Pepys (1999) Serum amyloid P component controls chromatin degradation and prevents antinuclear autoimmunity. Nature Med. 5 694.
217. E. Paul and M.C. Carroll (1999) SAP-less chromatin triggers systemic lupus erythematosus. Nature Med. 5 607.
218. K.J. Erb, B. Ruger, M. von Brevern, B. Ryffel, A. Schimpl and K. Rivett (1997) Constitutive expression of interleukin (IL)-4 in vivo causes autoimmune-type disorders in mice. J. Exp. Med. 185 329.
219. W. Muller, R. Kuhn and K. Rajewsky (1991) Major histocompatibility complex class II hyperexpression on B cells in interleukin 4-transgenic mice does not lead to B cell proliferation and hypergammaglobulinemia. Eur. J. Immunol. 21 921.
220. H.J. Burstein, R.I. Tepper, P. Leder and A.K. Abbas (1991) Humoral immune functions in IL-4 transgenic mice. J. Immunol. 147 2950.
221. R.I. Tepper, D.A. Levinson, B.Z. Stanger, J. Campos-Torres, A.K. Abbas and P. Leder (1990) IL-4 induces allergic-like inflammatory disease and alters T cell development in transgenic mice. Cell 62 457.
222. D.B. Lewis, C.C. Yu, K.A. Forbush, J. Carpenter, T.A. Sato, A. Grossman, D.H. Liggitt and R.M. Perlmutter (1991) Interleukin 4 expressed in situ selectively alters thymocyte development. J. Exp. Med. 173 89.
223. M. Santiago, L. Fossati, C. Jacquiet, W. Muller, S. Izui and L. Reininger (1997) Interleukin-4 protects against a genetically linked lupus-like autoimmune syndrome. J. Exp. Med. 185 65.
224. M.T. Worthington, B.T. Amann, D. Nathans and J.M. Berg (1996) Metal binding properties and secondary structure of the zinc-binding domain of Nup475. Proc. Natl. Acad. Sci. USA 93 13754.
225. G.A. Taylor, E. Carballo, D.M. Lee, W.S. Lai, M.J. Thompson, D.D. Patel, D. Schenkman, G.S. Gilkeson, H.E. Broxmeyer, B.F. Haynes and P.J. Blackshear (1996) A pathogenetic role for TNF alpha in the syndrome of cachexia, arthritis, and autoimmunity resulting from tristetraprolin (TTP) deficiency. Immunity 4 445.
226. E. Carballo, G.S. Gilkeson and P.J. Blackshear (1997) Bone marrow transplantation reproduces the tristetraprolin-deficiency syndrome in recombination activating gene-2 (-/-) mice: Evidence that monocyte/macrophage progenitors may be responsible for TNFalpha overproduction. J. Clin. Invest. 100 986.
227. E. Carballo, W.S. Lai and P.J. Blackshear (1998) Feedback inhibition of macrophage tumor necrosis factor-alpha production by tristetraprolin. Science 281 1001.
228. J. Rothe, W. Lesslauer, H. Lotscher, Y. Lang, P. Koebel, F. Kontgen, A. Althage, R. Zinkermagel, M. Steinmetz and H. Bluethmann (1993) Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature 364 798.
229. K. Pfeffer, T. Matsuyama, T.M. Kundig, A. Wakeham, K. Kishihara, A. Shahinian, K. Wiegmann, P.S. Ohashi, M. Kronke and T.W. Mak (1993) Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock yet succumb to L. monocytogenes infection. Cell 73 457.
230. T. Zhou, C.K. Edwards, P. Yang, Z. Wang, H. Bluethmann and J.D. Mountz (1996) Greatly accelerated lymphadenopathy and autoimmune disease in Ipr mice lacking tumor necrosis factor receptor I. J. Immunol. 156 2661.
231. H.K. Sytwu, R.S. Liblau and H.O. McDevitt (1996) The roles of Fas/APO-1 (CD95) and TNF in antigen-induced programmed cell death in T cell receptor transgenic mice. Immunity 5 17.
232. D. Balomenos, J. Martin-Caballero, M.I. Garcia, J. Prieto, J.M. Flores, M. Serrano and A.C. Martinez (2000) The cell cycle inhibitor p21 controls T-cell proliferation and sex-linked lupus development. Nature Med. 6 171.
233. M.L. Santiago-Raber, B.R. Lawson, W. Dummer, M. Barnhouse, S. Koundouris, C.B. Wilson, D.H. Kono and A.N. Theofilopoulos (2001) The role of cyclin kinase inhibitor p 21 in systemic autoimmunity. J. Immunol. 167 4067.
234. B.R. Lawson, D.H. Kono and A.N. Theofilopoulos (2002) Deletion of p21 (WAF-1/Cip1) does not induce systemic autoimmunity in female BXSB mice. J. Immunol. 168 5928.
235. H. Sabzevari, S. Propp, D.H. Kono and A.N. Theofilopoulos (1997) G1 arrest and high expression of cyclin kinase and apoptosis inhibitors in accumulated activated/memory phenotype CD4+ cells of older lupus mice. Eur. J. Immunol. 27 1901.
236. D. Chui, M. Oh-Eda, Y.F. Liao, K. Panneerselvam, A. Lal, K.W. Marek, H.H. Freeze, K.W. Moremen, M.N. Fukuda and J.D. Marth (1997) Alpha-mannosidase-II deficiency results in dyserythropoiesis and unveils an alternate pathway in oligosaccharide biosynthesis. Cell 90 157.
237. K.W. Moremen, R.B. Trimble and A. Herscovics (1994) Glycosidases of the asparagine-linked oligosaccharide processing pathway. Glycobiology 4 113.
238. D. Chui, G. Sellakumar, R. Green, M. Sutton-Smith, T. McQuistan, K. Marek, H. Morris, A. Dell and J. Marth (2001) Genetic remodeling of protein glycosylation in vivo induces autoimmune disease. Proc. Natl. Acad. Sci. USA 98 1142.
239. M. Demetriou, M. Granovsky, S. Quaggin and J.W. Dennis (2001) Negative regulation of T-cell activation and autoimmunity by Mgat5 N-glycosylation. Nature 409 733.
240. N.L. Perillo, K.E. Pace, J.J. Seilhamer and L.G. Baum (1995) Apoptosis of T cells mediated by galectin-1. Nature 378 736.
241. G.N. Vespa, L.A. Lewis, K.R. Kozak, M. Moran, J.T. Nguyen, L.G. Baum and M.C. Miceli (1999) Galectin-1 specifically modulates TCR signals to enhance TCR apoptosis but inhibit IL-2 production and proliferation. J. Immunol. 162 799.
242. M. Napirei, H. Karsunky, B. Zevnik, H. Stephan, H.G. Mannherz and T. Moroy (2000) Features of systemic lupus erythematosus in Dnase1-deficient mice. Nature Genet. 25 177.
243. K. Yasutomo, T. Horiuchi, S. Kagami, H. Tsukamoto, C. Hashimura, M. Urushihara and Y. Kuroda (2001) Mutation of DNASE1 in people with systemic lupus erythematosus. Nature Genet. 28 313.
244. J.D. Inglis, M. Lee and R.E. Hill (1993) Emk. a protein kinase with homologs in yeast maps to mouse chromosome 19. Mamm Genome 4 401.
245. S. Guo and K.J. Kemphues (1995) par-1, a gene required for establishing polarity in C. elegans embryos encodes a putative Ser/Thr kinase that is asymmetrically distributed. Cell 81 611.
246. J.B. Hurov, T.S. Stappenbeck, C.M. Zmasek, L.S. White, S.H. Ranganath, J.H. Russell, A.C. Chan, K.M. Murphy and H. Piwnica-Worms (2001) Immune system dysfunction and autoimmune disease in mice lacking Emk (Par-1) protein kinase. Mol. Cell. Biol. 21 3206.
247. S. Bessone, F. Vidal, Y. Le Bouc, J. Epelbaum, M.T. Bluet-Pajot and M. Darmon (1999) EMK protein kinase-null mice: Dwarfism and hypofertility associated with alterations in the somatotrope and prolactin pathways. Dev. Biol. 214 87.
248. L.M. Zipper and R.T. Mulcahy (2002) The Keapl BTB/POZ dimerization function is required to sequster Nrf2 in cytoplasm. J. Biol. Chem.
249. T. Ishii, K. Itoh and M. Yamamoto (2002) Roles of Nrf2 in activation of antioxidant enzyme genes via antioxidant responsive elements. Methods Enzymol. 348 182.
250. K. Yoh, K. Itoh, A. Enomoto, A. Hirayama, N. Yamaguchi, M. Kobayashi, N. Morito, A. Koyama, M. Yamamoto and S. Takahashi (2001) Nrf2-deficient female mice develop lupus-like autoimmune nephritis. Kidney. Int. 60 1343.
251. W. Ollier, E. Davies, N. Snowden, J. Alldersea, A. Fryer, P. Jones and R. Strange (1996) Association of homozygosity for glutathione-S-transferase GSTM1 null alleles with the Ro+/La-autoantibody profile in patients with systemic lupus erythematosus. Arthritis Rheum. 39 1763.
252. K.D. Poss and S. Tonegawa (1997) Heme oxygenase 1 is required for mammalian iron reutilization. Proc. Natl. Acad. Sci. USA 94 10919.
253. M.J. Shlomchik, M.P. Madaio, D. Ni, M. Trounstein and D. Huszar (1994) The role of B cells in Ipr/Ipr-induced autoimmunity. J. Exp. Med. 180 1295.
254. O.T. Chan, M.P. Madaio and M.J. Shlomchik (1999) B cells are required for lupus nephritis in the polygenic, Fas-intact MRL model of sytemic autoimmunity. J. Immunol. 163 3592.
255. O. Chan and M.J. Shlomchik (1998) A new role for B cells in systemic autoimmunity: B cells promote spontaneous T cell activation in MRL-Ipr/Ipr mice. J. Immunol. 160 51.
256. O.T. Chan and M.J. Shlomchik (2000) B cells promote CD8+ T cell activation in MRL-Fas(Ipr) mice independently of MHC class I antigen presentation. J. Immunol. 164 1658.
257. O.T. Chan, L.G. Hannum, A.M. Haberman, M.P. Madaio and M.J. Shlomchik (1999) A novel mouse with B cells but lacking serum antibody reveals an antibody-independent role for B cells in murine lupus. J. Exp. Med. 189 1639.
258. A.M. Jevnikar, M.J. Grusby and L.H. Glimcher (1994) Preventation of nephritis in major histocompatibility complex class II-deficient MRL-Ipr mice. J. Exp. Med. 179 1137.
259. D.R. Koh, A. Ho, A. Rahemtulla, W.P. Fung-Leung, H. Griesser and T.W. Mak (1995) Murine lupus in MRL/Ipr mice lacking CD4 or CD8 T cells. Eur. J. Immunol. 25 2558.
260. T. Giese and W.F. Davidson (1995) In CD8+ T cell-deficient Ipr/Ipr mice, CD4+B220+ and CD4+B220- T cells replace B220+ double-negative T cells as the predominant populations in enlarged lymph nodes. J. Immunol. 154 4986.
261. T. Ohteki, M. Iwamoto, S. Izui and H.R. MacDonald (1995) Reduced development of CD4-8-B220+ T cells but normal autoantibody production in Ipr/Ipr mice lacking major histocompatibility complex class I molecules. Eur. J. Immunol. 25 37.
262. M.A. Maldonado, R.A. Eisenberg, E. Roper, P.L. Cohen and B.L. Kotzin (1995) Greatly reduced lymphoproliferation in Ipr mice lacking major histocompatibility complex class I. J. Exp. Med. 181 641.
263. G.J. Christianson, R.L. Blankenburg, T.M. Duffy, D. Panka, J.B. Roths, A. Marshak-Rothstein and D.C. Roopenian (1996) beta2-microglobulin dependence of the lupus-like autoimmune syndrome of MRL-Ipr mice. J. Immunol. 156 4932.
264. O.T. Chan, V. Paliwal, J.M. McNiff, S.H. Park, A. Bendelac and M.J. Shlomchik (2001) Deficiency in beta(2)-microglobulin, but not CD1, accelerates spontaneous lupus skin disease while inhibiting nephritis in MRL-Fas(Ipr) nice: An example of disease regulation at the organ level. J. Immunol. 167 2985.
265. S.Y. Chen, Y. Takeoka, A.A. Ansari, R. Boyd, D.M. Klinman and M.E. Gershwin (1994) The natural history of disease expression in CD4 and CD8 gene-deleted New Zealand black (NZB) mice. J. Immunol. 157 2676.
266. S.Y. Chen, Y. Takeoka, L. Pike-Nobile, A.A. Ansari, R. Boyd and M.E. Gershwin (1997) Autoantibody production and cytokine profiles of MHC class I (beta2-microglobulin) gene deleted New Zealand black (NZB) mice. Clin. Immunol. Immunopathol. 84 318.
267. S.L. Peng, J. Cappadona, J.M. McNiff, M.P. Madaio, M.J. Owen, A.C. Hayday and J. Craft (1998) Pathogenesis of autoimmunity in alphabeta T cell-deficient lupus-prone mice. Clin. Exp. Immunol. 111 107.
268. S.L. Peng, M.P. Madaio, D.P. Hughes, I.N. Crispe, M.J. Owen, Wen, A.C. Hayday and J. Craft (1996) Murine lupus in the absence of alpha beta T cells. J. Immunol. 156 4041.
269. S.L. Peng and J. Craft (1997) The regulation of murine lupus. Ann. N. Y. Acad. Sci. 815 128.
270. J. Craft, S. Peng, T. Fujii, M. Okada and S. Fatenejad (1999) Autoreactive T cells in murine lupus: Origins and roles in autoantibody production. Immunol. Res. 19 245.
271. S.L. Peng, J. Moslehi, M.E. Robert and J. Craft (1998) Perforin protects against autoimmunity in lupus-prone mice. J. Immunol. 160 652.
272. J. Ma, J. Xu, M.P. Madaio, Q. Peng, J. Zhang, I.S. Grewal, R.A. Flavell and J. Craft (1996) Autoimmune Ipr/Ipr mice deficient in CD40 ligand: Spontaneous Ig class switching with dichotomy of autoantibody responses. J. Immunol. 157 417.
273. S.L. Peng, J.M. McNiff, M.P. Madaio, J. Ma, M.J. Owen, R.A. Flavell, A.C. Hayday and J. Craft (1997) alpha-beta T cell regulation and CD40 ligand dependence in murine systemic autoimmunity. J. Immunol. 158 2464.
274. Y. Tada, K. Nagasawa, A. Ho, F. Morito, S. Koarada, O. Ushiyama, N. Suzuki, A. Ohta and T.W. Mak (1999) Role of the costimulatory molecule CD28 in the development of lupus in MRL/Ipr mice. J. Immunol. 163 3153.
275. B. Liang, R.J. Gee, M.J. Kashgarian, A.H. Sharpe and M.J. Mamula (1999) B7 costimulation in the development of lupus: Autoimmunity arises either in the absence of B7.1/B7.2 or in the presence of anti-B7.1/B7.2 blocking antibodies. J. Immunol. 163 2322.
276. A. Nakajima, M. Azuma, S. Kodera, S. Nuriya, A. Terashi, M. Abe, S. Hirose, T. Shirai, H. Yagita and K. Okumura (1995) Preferential dependence of autoantibody production in murine lupus on CD86 costimulatory molecule. Eur. J. Immunol. 25 3060.
277. S.L. Peng, J. Moslehi and J. Craft (1997) Roles of interferon-gamma and interleukin-4 in murine lupus. J. Clin. Invest. 99 1936.
278. C. Haas, B. Ryffel and H.M. Le (1997) IFN-gamma is essential for the development of autoimmune glomerulonephritis in MRL/Ipr mice. J. Immunol. 158 5484.
279. D. Balomenos, R. Rumold and A.N. Theofilopoulos (1998) Interferon-gamma is required for lupus-like disease and lymphoaccumulation in MRL-Ipr mice. J. Clin. Invest. 101 364.
280. C. Haas, B. Ryffel and M. Le Hir (1998) IFN-gamma receptor deletion prevents autoantibody production and glomerulonephritis in lupus-prone (NZB x NZW)F1 mice. J. Immunol. 160 3713.
281. D.H. Kono, D. Balomenos, D.L. Pearson, M.S. Park, B. Hildebrandt, P. Hultman and K.M. Pollard (1998) The prototypic Th2 autoimmunity induced by mercury is dependent on IFN-gamma and not Th1/Th2 imbalance. J. Immunol. 161 234.
282. A. Schwarting, T. Wada, K. Kinoshita, G. Tesch and V.R. Kelley (1998) IFN-gamma receptor signaling is essential for the initiation, acceleration and destruction of autoimmune kidney disease in MRL-Fas(Ipr) mice. J. Immunol. 161 494.
283. B.R. Lawson, G.J. Prud'homme, Y. Chang, H.A. Gardner, J. Kuan, D.H. Kono and A.N. Theofilopoulos (2000) Treatment of murine lupus with cDNA encoding IFN-gammaR/Fc. J. Clin. Invest. 106 207.
284. I.C. Ho and L.H. Glimcher (2002) Transcription: Tantalizing times for T cells. Cell 109(Suppl.), S109.
285. S.L. Peng, S.J. Szabo and L.H. Glimcher (2002) T-bet regulates IgG class switching and pathogenic autoantibody production. Proc. Natl. Acad. Sci. USA 99 5545.
286. D.S. Robinson and A. O'Garra (2002) Further check-points in Th1 development. Immunity 16 755.
287. F.P. Huang, G.J. Feng, G. Lindop, D.I. Stott and F.Y. Liew (1996) The role of interleukin 12 and nitric oxide in the development of spontaneous autoimmune disease in MRL/MP-Ipr/Ipr mice. J. Exp. Med. 183 1447.
288. X. Fan, B. Oertli and R.P. Wuthrich (1997) Up-regulation of tubular epithelial interleukin-12 in autoimmune MRL-Fas(Ipr) mice with renal injury. Kidney Int. 51 79.
289. H. Xu, H. Kurihara, T. Ito, S. Nakajima, E. Hagiwara, H. Yamanokuchi and A. Asari (2001) IL-12 enhances lymphoaccumulation by suppressing cell, death of T cells in MRL-Ipr/Ipr mice. J. Autoimmun. 16 87.
290. T. Yasuda, T. Yoshimoto, A. Tsubura and A. Matsuzawa (2001) Clear suppression of Th1 responses but marginal amelioration of autoimmune manifestations by IL-12p40 transgene, in MRL-FAS(Iprcg)/FAS(Iprcg) mice. Cell Immunol. 210 77.
291. A. Nakajima, S. Hirose, H. Yagita and K. Okumura (1997) Role of IL-4 and IL-12 in the development of lupus in NZB/W F1 mice. J. Immunol. 158 1466.
292. E. Hagiwara, T. Okubo, I. Aoki, S. Ohno, T. Tsuji, A. Ihata, A. Ueda, A. Shirai, K. Okuda, J. Miyazaki and Y. Ishigatsubo (2000) IL-12-encoding plasmid has a beneficial effect on spontaneous autoimmune disease in MRL/MP-Ipr/Ipr mice. Cytokine 12 1035.
293. D.H. Kono, D. Balomenos, M.S. Park and A.N. Theofilopoulos (2000) Development of lupus in BXSB mice is independent of IL-4. J. Immunol. 164 38.
294. H. Ishida, R. Hastings, J. Kearney and M. Howard (1992) Continuous anti-interleukin 10 antibody administration depletes mice of Ly-1 B cells but not conventional B cells. J. Exp. Med. 175 1213.
295. H. Ishida, T. Muchamuel, S. Sakaguchi, S. Andrade, S. Menon and M. Howard (1994) Continuous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZB/W F1 mice. J. Exp. Med. 179 305.
296. L. Llorente, W. Zou, Y. Levy, Y. Richaud-Patin, J. Wijdenes, J. Alcocer-Varela, B. MoreI-Fourrier, J.C. Brouet, D. Alarcon-Segovia, P. Galanaud, et al. (1995) Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus. J. Exp. Med. 181 839.
297. Z. Yin, G. Bahtiyar, N. Zhang, L. Liu, P. Zhu, M.E. Robert, J. McNiff, M.P. Madaio and J. Craft (2002) IL-10 regulates murine lupus. J. Immunol. 169 2148.
298. S. Ramachandra, R.A. Metcalf, T. Fredrickson, G.E. Marti and E. Raveche (1996) Requirement for increased IL-10 in the development of B-1 lymphoproliferative disease in a murine model of CLL. J. Clin. Invest. 98 1788.
299. K. Balabanian, A. Foussat, L. Bouchet-Delbos, J. Couderc, R. Kryzsiek, A. Amara, F. Baleux, A. Portier, P. Galanaud and D. Emilie (2002) Interleukin-10 modulates the sensitivity of peritoneal B lymphocytes to chemokines with opposite effects on stromal cell-derived factor-1 and B-lymphocyte chemoattractant. Blood 99 427.
300. N. Watanabe, K. Ikuta, S. Nisitani, T. Chiba and T. Honjo (2002) Activation and differentiation of autoreactive B-1 cells by interleukin 10 induce autoimmune hemolytic anemia in Fas-deficient antierythrocyte immunoglobulin transgenic mice. J. Exp. Med. 196 141.
301. A. O'Garra, R. Chang, N. Go, R. Hastings, G. Haughton and M. Howard (1992) Ly-1 B (B-1) cells are the main source of B cell-derived interleukin 10. Eur. J. Immunol. 22 711.
302. S. Ashkar, G.F. Weber, V. Panoutsakopoulou, M.E. Sanchirico, M. Jansson, S. Zawaideh, S.R. Rittling, D.T. Denhardt, M.J. Glimcher and H. Cantor (2000) Eta-1 (osteopontin): An early component of type-1 (cell-mediated) immunity. Science 287 860.
303. G.F. Weber and H. Contor (2001) Differential roles of osteopontin/Eta-1 in early and late Ipr disease. Clin. Exp. Immunol. 126 578.
304. R. Patarca, F.Y. Wei, P. Singh, M.I. Morasso and H. Cantor (1990) Dysregulated expression of the T cell cytokine Eta-1 in CD4-8-lymphocytes during the development of murine autoimmune disease. J. Exp. Med. 172 1177.
305. D. Balomenos, R. Rumold and A.N. Theofilopoulos (1997) The proliferative in vivo activities of Ipr double-negative T cells and the primary role of p59fyn in their activation and expansion. J. Immunol. 159 2265.
306. W.P. Brooks and M.A. Lynes (2001) Effects of hemizygous CD45 expression in the autoimmune Fasl(gld/gld) syndrome. Cell. Immunol. 212 24.
307. H. Watanabe, G. Garnier, A. Circolo, R.A. Wetsel, P. Ruiz, V.M. Holers, S.A. Boackle, H.R. Colten and G.S. Gilkeson (2000) Modulation of renal disease in MRL/lpr mice genetically deficient in the alternative complement pathway factor B. J. Immunol. 164 786.
308. J. Passwell, G.F. Schreiner, M. Nonaka, H.U. Beuscher and H.R. Colten (1988) Local extrahepatic expression of complement genes C3, factor B, C2, and C4 is increased in murine lupus nephritis. J. Clin. Invest. 82 1676.
309. H. Sekine, C.M. Reilly, I.D. Molano, G. Garnier, A. Circolo, P. Ruiz, V.M. Holers, S.A. Boackle and G.S. Gilkeson (2001) Complement component C3 is not required for full expression of immune complex glomerulonephritis in MRL/lpr mice. J. Immunol. 166 6444.
310. S. Einav, O.O. Pozdnyakova, M. Ma and M.C. Carroll (2002) Complement C4 is protective for lupus disease independent of C3. J. Immunol. 168 1036.
311. L. Bao, M. Haas, S.A. Boackle, D.M. Kraus, P.N. Cunningham, P. Park, J.J. Alexander, R.K. Anderson, K. Culhane, V.M. Holers and R.J. Quigg (2002) Transgenic expression of a soluble complement inhibitor protects against renal disease and promotes survival in MRL/lpr mice. J. Immunol. 168 3601.
312. M.C. Pickering, H.T. Cook, J. Warren, A.E. Bygrave, J. Moss, M.J. Walport and M. Botto (2002) Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor H. Nature Genet. 31 424.
313. C.M. Lloyd, J.A. Gonzalo, D.J. Salant, J. Just and J.C. Gutierrez-Ramos (1997) Intercellular adhesion molecule-1 deficiency prolongs survival and protects against the development of pulmonary inflammation during murine lupus. J. Clin. Invest. 100 963.
314. D.C. Bullard, P.D. King, M.J. Hicks, B. Dupont, A.L. Beaudet and K.B. Elkon (1997) Intercellular adhesion molecule-1 deficiency protects MRL/MpJ-Fas(lpr) mice from early lethality. J. Immunol. 159 2058.
315. G.S. Gilkeson, J.S. Mudgett, M.F. Seldin, P. Ruiz, A.A. Alexander, M.A. Misukonis, D.S. Pisetsky and J.B. Weinberg (1997) Clinical and serologic manifestations of autoimmune disease in MRL-lpr/lpr mice lacking nitric oxide synthase type 2. J. Exp. Med. 186 365.
316. R. Clynes, C. Dumitru and J.V. Ravetch (1998) Uncoupling of immune complex formation and kidney damage in autoimmune glomerulonephritis. Science 279 1052.
317. S.Y. Park, S. Ueda, H. Ohno, Y. Hamano, M. Tanaka, T. Shiratori, T. Yamazaki, H. Arase, N. Arase, A. Karasawa, S. Sato, B. Ledermann, Y. Kondo, K. Okumura, C. Ra and T. Saito (1998) Resistance of Fc receptor-deficient mice to fatal glomerulonephritis. J. Clin. Invest. 102 1229.
318. G.H. Tesch, S. Maifert, A. Schwarting, B.J. Rollins and V.R. Kelley (1999) Monocyte chemoattractant protein 1-dependent leukocytic infiltrates are responsible for autoimmune disease in MRL-Fas(lpr) mice. J. Exp. Med. 190 1813.
319. S. Gilfillan, C. Benoist and D. Mathis (1995) Mice lacking terminal deoxynucleotidyl transferase: Adult mice with a fetal antigen receptor repertoire. Immunol. Rev. 148 201.
320. T. Komori, A. Okada, V. Stewart and F.W. Alt (1993) Lack of N regions in antigen receptor variable region genes of TdT-deficient lymphocytes. Science 261 1171.
321. T. Komori, L. Pricop, A. Hatakeyama, C.A. Bona and F.W. Alt (1996) Repertoires of antigen receptors in Tdt congenitally deficient mice. Int. Rev. Immunol. 13 317.
322. S. Weller, C. Conde, A.M. Knapp, H. Levallois, S. Gilfillan, J.L. Pasquali and T. Martin (1997) Autoantibodies in mice lacking terminal deoxynucleotidyl transferase: Evidence for a role of N region addition in the polyreactivity and in the affinities of anti-DNA antibodies. J. Immunol. 159 3890.
323. I.D. Molano, M.K. Wloch, A.A. Alexander, H. Watanabe and G.S. Gilkeson (2000) Effect of a genetic deficiency of terminal deoxynucleotidyl transferase on autoantibody production by C57BL6 fas(lpr) mice. Clin. Immunol. 94 24.
324. C.C. Allende and J.E. Allende (1998) Promiscuous subunit interactions: A possible mechanism for the regulation of protein kinase CK2. J. Cell. Biochem. Suppl. 31 129.
325. D.C. Seldin and P. Leder (1995) Casein kinase II alpha transgene-induced murine lymphoma: Relation to theileriosis in cattle. Science 267 894.
326. X. Xu, E. Landesman-Bollag, P.L. Channavajhala and D.C. Seldin (1999) Murine protein kinase CK2: gene and oncogene. Mol. Cell. Biochem. 191 65.
327. R.F. Spurney, P. Ruiz, D.S. Pisetsky and T.M. Coffman (1991) Enhanced renal leukotriene production in murine lupus: Role of lipoxygenase metabolites. Kidney Int. 39 95.
328. U.H. Rudofsky, B.D. Evans, S.L. Balaban, V.D. Mottironi and A.E. Gabrielsen (1993) Differences in expression of lupus nephritis in New Zealand mixed H-2z homozygous inbred strains of mice derived from New Zealand black and New Zealand white mice: Origins and initial characterization. Lab. Invest. 68 419.
329. L. Fossati, S. Takahashi, R. Merino, M. Iwamoto, J.P. Aubry, M. Nose, Spach, R. Motta and S. Izui (1993) An MRL/MpJ-lpr/lpr substrain with a limited expansion of lpr double-negative T cells and a reduced autoimmune syndrome. Int. Immunol. 5 525.
330. K. Kinjoh, M. Kyogoku and R.A. Good (1993) Genetic selection for crescent formation yields mouse strain with rapidly progressive glomerulonephritis and small vessel vasculitis. Proc. Natl. Acad. Sci. USA 90 3413.
331. R. Kofler, P.J. McConahey, M.A. Duchosal, R.S. Balderas, A.N. Theofilopoulos and F.J. Dixon (1991) An autosomal recessive gene that delays expression of lupus in BXSB mice. J. Immunol. 146 1375.
332. S. Vidal, C. Gelpi and J.L. Rodriguez-Sanchez (1994) (SWR x SJL)F1 mice: A new model of lupus-like disease. J. Exp. Med. 179 1429.
333. S.E. Walker, R.H. Gray, M. Fulton, R.D. Wigley and B. Schnitzer (1978) Palmerston North mice, a new animal model of systemic lupus erythematosus. J. Lab. Clin. Med. 92 932.
334. J.S. Bignon and K.A. Siminovitch (1994) Identification of PTP1C mutation as the genetic defect in motheaten and viable motheaten mice: A step toward defining the roles of protein tyrosine phosphatases in the regulation of hemopoietic cell differentiation and function. Clin. Immunol. Immunopathol. 73 168.
335. K.M. Pollard and P. Hultman (1997) Effects of mercury on the immune system. Met. Ions. Biol. Syst. 34 421.
336. R.L. Rubin (1997) Drug-induced lupus. 47 871.
337. M. Satoh, A. Kumar, Y.S. Kanwar and W.H. Reeves (1995) Anti-nuclear antibody production and immune-complex glomerulonephritis in BALB/c mice treated with pristane. Proc. Natl. Acad. Sci. USA 92 10934.
338. S. Mendlovic, B.H. Fricke, Y. Shoenfeld, R. Bakimer and E. Mozes (1990) The genetic regulation of the induction of experimental SLE. Immunology 69 228.
339. T.J. Vyse, L. Morel, F.J. Tanner, E.K. Wakeland and B.L. Kotzin (1996) Backcross analysis of genes linked to autoantibody production in New Zealand White mice. J. Immunol. 157 2719.
340. S. Xie, S. Chang, P. Yang, C. Jacob, A. Kaliyaperumal, S.K. Datta and C. Mohan (2001) Genetic contributions of nonautoimmune SWR mice toward lupus nephritis. J. Immunol. 167 7141.
341. D.H. Kono, M.S. Park, A. Szydlik, K.M. Haraldsson, J.D. Kuan, D.L. Pearson, P. Hultman and K.M. Pollard (2001) Resistance to xenobiotic-induced autoimmunity maps to chromosome 1. J. Immunol. 167 2396.
342. S.T. Waters, S.M. Fu, F. Gaskin, U.S. Deshmukh, S.S. Sung, C.C. Kannapell, K.S. Tung, S.B. McEwen and M. McDuffie (2001) NZM2328: A new mouse model of systemic lupus erythematosus with unique genetic susceptibility loci. Clin. Immunol. 100 372.
343. T.J. Vyse, S.J. Rozzo, C.G. Drake, S. Izui and B.L. Kotzin (1997) Control of multiple autoantibodies linked with a lupus nephritis susceptibility locus in New Zealand black mice. J. Immunol. 158 5566.
344. S.J. Rozzo, T.J. Vyse, C.G. Drake and B.L. Kotzin (1996) Effect of genetic background on the contribution of New Zealand black loci to autoimmune lupus nephritis. Proc. Natl. Acad. Sci. USA 93 15164.
345. L. Gu, A. Weinreb, X.P. Wang, D.J. Zack, J.H. Qiao, R. Weisbart and A.J. Lusis (1998) Genetic determinants of autoimmune disease and coronary vasculitis in the MRL-lpr/lpr mouse model of systemic lupus erythematosus. J. Immunol. 161 6999.
346. Z.S. Rahman, S.K. Tin, P.N. Buenaventura, C.H. Ho, E.P. Yap, R.Y. Yong and D.R. Koh (2002) A novel susceptibility locus on chromosome 2 in the (New Zealand Black × New Zeland White) F1 hybrid mouse model of systemic lupus erythematosus. J. Immunol. 168 3042.
347. K. Ochiai, S. Ozaki, A. Tanino, S. Watanabe, T. Ueno, K. Mitsui, J. Toei, Y. Inada, S. Hirose, T. Shirai and H. Nishimura (2000) Genetic regulation of antierythrocyte autoantibodies and splenomegaly in autoimmune hemolytic anemia-prone new zealand black mice. Int. Immunol. 12 1.
348. C.G. Drake, S.K. Babcock, E. Palmer and B.L. Kotzin (1994) Genetic analysis of the NZB contribution to lupus-like autoimmune disease in (NZB×NZW)F1 mice. Proc. Natl. Acad. Sci. USA 91 4062.
349. S. Hirose, H. Tsurui, H. Nishimura, Y. Jiang and T. Shirai (1994) Mapping of a gene for hypergammaglobulinemia to the distal region on chromosome 4 in NZB mice and its contribution to systemic lupus erythematosus in (NZB×NZW)F1 mice. Int. Immunol. 6 1857.
350. Y. Jiang, S. Hirose, Y. Hamano, S. Kodera, H. Tsurui, M. Abe, K. Terashima, S. Ishikawa and T. Shirai (1997) Mapping of a gene for the increased susceptibility of B1 cells to Mott cell formation in murine autoimmune disease. J. Immunol. 158 992.
351. S. Nakatsuru, M. Terada, M. Nishihara, J. Kamogawa, T. Miyazaki, W.M. Qu, K. Morimoto, C. Yazawa, H. Ogasawara, Y. Abe, K. Fukui, G. Ichien, M.R. Ito, S. Mori, Y. Nakamura and M. Nose (1999) Genetic dissection of the complex pathological manifestations of collagen disease in MRL/lpr mice. Pathol. Int. 49 974.
352. T.J. Vyse, C.G. Drake, S.J. Rozzo, E. Roper, S. Izui and B.L. Kotzin (1996) Genetic linkage of IgG autoantibody production in relation to lupus nephritis in New Zealand hybrid mice. J. Clin. Invest. 98 1762.
353. M.E. Haywood, T.J. Vyse, A. McDermott, E.M. Thompson, A. Ida, M.J. Walport, S. Izui and B.J. Morley (2001) Autoantigen glycoprotein 70 expression is regulated by a single locus, which acts as a checkpoint for pathogenic anti-glycoprotein 70 autoantibody production and hence for the corresponding development of severe nephritis, in lupus-prone PXSB mice. J. Immunol. 167 1728.
354. S.J. Rozzo, T.J. Vyse, K. Menze, S. Izui and B.L. Kotzin (2000) Enhanced susceptibility to lupus contributed from the nonautoimmune C57BL/10, but not C57BL/6, genome. J. Immunol. 164 5515.
355. M.L. Santiago, C. Mary, D. Parzy, C. Jacquet, X. Montagutelli, R.M. Parkhouse, R. Lemoine, S. Izui and L. Reininger (1998) Linkage of a major quantitative trait locus to Yaa gene-induced lupus-like nephritis in (NZW×C57BL/6)F1 mice. Eur. J. Immunol. 28 4257.
356. J. Kamogawa, M. Terada, S. Mizuki, M. Nishihara, H. Yamamoto, S. Mori, Y. Abe, K. Morimoto, S. Nakatsuru, Y. Nakamura and M. Nose (2002) Arthritis in MRL/lpr mice is under the control of multiple gene loci with an allelic combination derived from the original inbred strains. Arthritis Rheum. 46 1067.
357. R.M. Tucker, T.J. Vyse, S. Rozzo, C.L. Roark, S. Izui and B.L. Kotzin (2000) Genetic control of glycoprotein 70 autoantigen production and its influence on immune complex levels and nephritis in murine lupus. J. Immunol. 165 1665.
358. M.J. Walport, K.A. Davies and M. Botto (1998) C1q and systemic lupus erythematosus. Immunobiology 199 265.
359. D.A. Mitchell, M.C. Pickering, J. Warren, L. Fossati-Jimack, J. Cortes-Hernandez, H.T. Cook, M. Botto and M.J. Walport (2002) C1q deficiency and autoimmunity: The effects of genetic background on disease expression. J. Immunol. 168 2538.
360. T.L. O'Keefe, G.T. Willrams, F.D. Batista and M.S. Neuberger (1999) Deficiency in CD22, a B cell-specific inhibitory receptor, is sufficient to predispose to development of high affinity autoantibodies. J. Exp. Med. 189 1307.
361. W.S. Lai, E. Carballo, J.R. Strum, E.A. Kennington, R.S. Phillips and P.J. Blackshear (1999) Evidence that triste traprolin binds to AU-rich elements and promotes the deadenylation and destabilization of tumor necrosis factor alpha m RNA. Mol. Cell. Biol. 19 4311.
362. C.C. Yu, T.S. Yen, C.A. Lowell and A.L. DeFranco (2001) Lupus-like kidney disease in mice deficient in the Src family tyrosine kinases Lyn and Fyn. Curr. Biol. 11 34.
363. Z. Chen, S.B. Koralov and G. Kelsoe (2000) Complement C4 inhibits systemic autoimmunity through a mechanism independent of complement receptors CR1 and CR2. J. Exp. Med. 192 1339.
364. J.L. Goulet, R.C. Griffiths, P. Ruiz, R.F. Spurney, D.S. Pisetsky, B.H. Koller and T.M. Coffman (1999) Deficiency of 5-lupoxygenase abolishes sex-related survival differences in MRL-lpr/lpr mice. J. Immunol. 163 359.
365. M.S. Chesnutt, B.K. Finck, N. Killeen, M.K. Connolly, H. Goodman and D. Wofsy (1998) Enhanced lympho-proliferation and diminished autoimmunity in CD4-deficient MRL/lpr mice. Clin. Immunol. Immunopathol. 87 23.
366. V. Cattell (1999) Nitric oxide and glomerulonephritis. Semin. Nephrol. 19 277.
367. S.L. Peng and J. Craft (1996) T cells in murine lupus: Propagation and regulation of disease. Mol. Biol. Rep. 23 247.
368. S.L. Peng, M.P. Madaio, A.C. Hayday and J. Craft (1996) Propagation and regulation of systemic autoimmunity by gammadelta T cells. J. Immunol. 157 5689.
369. L. Wen, W. Pao, F.S. Wong, Q. Peng, J. Craft, B. Zheng, G. Kelsoe, L. Dianda, M.J. Owen and A.C. Hayday (1996) Germinal center formation, immunoglobulin class switching, and autoantibody production driven by “non alpha/beta” T cells. J. Exp. Med. 183 2271.
370. K. Kinoshita, G. Tesch, A. Schwarting, R. Maron, A.H. Sharpe and V.R. Kelley (2000) Costimulation by B7-1 and B7-2 is required for autoimmune disease in MRL-fasfpr mice. J. Immunol. 164 6046.
371. T. Paisansinsup, A.N. Vallejo, H. Luthra and C.S. David (2001) HLA-DR modulates autoantibody repertoire, but not mortality, in a humanized mouse model of systemic lupus erythematosus. J. Immunol. 167 4083.
372. D. Kontoyiannis and G. Kollias (2000) Accelerated autoimmunity and lupus nephritis in NZB mice with an engineered heterozygous deficiency in tumor, necrosis factor. Eur. J. Immunol. 30 2038.
373. C. Conde, S. Weller, S. Gilfillan, L. Marcellin, T. Martin and J.L. Pasquali (1998) Terminal deoxynucleotidyl transferase deficiency reduces the incidence of autoimmune nephritis in (New Zealand Black x New Zealand White)F1 mice. J. Immunol. 161 7023.
374. A.J. Feeney, B.R. Lawson, D.H. Kono and A.N. Theofilopoulos (2001) Terminal deoxynucleotidyl transferase deficiency decreases autoimmune disease in MRL-Fasfpr mice. J Immunol. 167 3486.
375. I.R. Rifkin, P.L. Channavajhala, H.L. Kiefer, A.J. Carmack, E. Landesman-Bollag, B.C. Beaudette, B. Jersky, D.J. Salant, S.T. Ju, A. Marshak-Rothstein and D.C. Seldin (1998) Acceleration of Ipr lymphoproliferative and autoimmune disease by transgenic protein kinase CK2 alpha. J. Immunol. 161 5164.
376. R. Wilkinson, A.B. Lyons, D. Roberts, M.X. Wong, P.A. Bartley and D.E. Jackson (2002) Platelet endothelial cell adhesion molecule-1 (PECAM-1/CD31) acts as a regulator of B-cell development, B-cell antigen receptor (BCR)-mediated activation, and autoimmune disease. Blood 100 184.
377. M. Murga, O. Fernandez-Capetillo, S.J. Field, B. Moreno, L. R.B., Y. Fujiwara, D. Balomenos, A. Vicario, A.C. Carrera, S.H. Orkin, M.E. Greenberg and A.M. Zubiaga (2001) Mutation of E2F2 in mice causes enhanced T lymphocyte proliferation, leading to the development of autoimmunity. Immunity 15 959.
378. R.R. Singh, V. Saxena, S. Zang, L. Li, F.D. Finkelman, D.P. Witte and C.O. Jacob (2003) Differential contribution of IL-4 and STAT6 vs STAT4 to the development of lupus nephritis. J. Immunol. 170 4818.
379. T. Miwa, M.A. Maldonado, L. Zhou, X. Sun, H.Y. Luo, D. Cai, V.P. Werth, M.P. Madaio, R.A. Eisenberg and W.C. Song (2002) Deletion of decay-accelerating factor (CD55) exacerbates autoimmune disease development in MRL/lpr mice. Am. J. Pathol. 161 1077.
380. D. Seshasayee, P. Valdez, M. Yan, V.M. Dixit, D. Tumas and I.S. Grewal (2003) Loss of TACI causes fatal lymphoproliferation and autoimmunity, establishing TACI as an inhibitory BLyS receptor. Immunity 18 279.
381. J. Wang, J.C. Lo, A. Foster, P. Yu, H.M. Chen, Y. Wang, K. Tamada, L. Chen and Y.X. Fu (2001) The regulation of T cell homeostasis and autoimmunity by T cell-derived LIGHT. J. Clin. Invest. 108 1771.
382. M.L. Hibbs, K.W. Harder, J. Armes, N. Kountouri, C. Quilici, F. Casagranda, A.R. Dunn and D.M. Tarlinton (2002) Sustained activation of Lyn tyrosine kinase in vivo leads to autoimmunity. J. Exp. Med. 196 1593.
383. M.L. Santiago-Raber, R. Baccala, K.M. Haraldsson, D. Choubey, T.A. Stewart, D.H. Kono and A.N. Theofilopoulos (2003) Type-I interferon receptor deficiency reduces lupus-like disease in NZB mice. J. Exp. Med. 197 777.
384. Y. Miura-Shimura, K. Nakamura, M. Ohtsuji, H. Tomita, Y. Jiang, M. Abe, D. Zhang, Y. Hamano, H. Tsuda, H. Hashimoto, H. Nishimura, S. Taki, T. Shirai and S. Hirose (2002) C1q regulatory region polymorphism down-regulating murine C1q protein levels with linkage to lupus nephritis. J. Immunol. 169 1334.